The effects of a soy rich diet on serum lipids: The Menfis randomized trial

Maturitas

Volumn 41, Issue 2, 2002, Pages 97-104

  Chiechi, L M ^a   Secreto, G ^b   Vimercati, A ^a   Greco, P ^a   Venturelli, E ^b   Pansini, F ^c   Fanelli, M ^a   Loizzi, P ^a   Selvaggi, L ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c POLICLINICO   (Italy)

Author keywords

Cardiovascular health; Lipid profile; Menopause; Phytoestrogens; Soy

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NOMEGESTROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; ENDOMETRIUM; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; NORMAL HUMAN; PATIENT COMPLIANCE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RESISTANCE BLOOD VESSEL; SIDE EFFECT; SOYBEAN; TREATMENT OUTCOME; UTERINE ARTERY;

ADULT; APOLIPOPROTEINS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; ENDOMETRIUM; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIPOPROTEINS; MIDDLE AGED; PATIENT COMPLIANCE; POSTMENOPAUSE; SOYBEAN PROTEINS; TRIGLYCERIDES;

STAPHYLOCOCCUS PHAGE 187;

EID: 0037176790     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00259-6     Document Type: Article

References (38)

1. Cardiovascular health and disease in women
2. Menopause and risk factors for coronary heart disease
3. Influence of menopause on serum lipids and lipoproteins
4. Coronary heart disease risk factors in relation to the menopause
5. Effects of age and menopause on lipid metabolism in healthy women
6. Lipids and lipoproteins in women after oophorectomy and the response to oestrogen therapy
7. Some atherogenic concomitans of menopause: The Framingham study
8. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women
9. Women, lipoproteins and cardiovascular disease risk
10. Incidence of coronary heart disease and lipoprotein cholesterol levels
11. Serum lipids and lipoproteins as predictors of atherosclerosis
12. The triglyceride issue: A view from Framingham
13. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal Estrogen/Progestin Interventions (PEPI) trial
14. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: Analysis of studies published from 1974-2000
15. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
16. Hormone therapy to prevent disease and prolong life in postmenopausal women
17. Patient-specific decisions about hormone replacement therapy in postmenopausal women
18. A prospective study of postmenopausal estrogen therapy and coronary heart disease
19. Use of replacement estrogens and the risk of myocardial infarction
20. Guidelines for counselling postenopausal women about preventive hormone therapy
21. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopusal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program
22. Breast cancer and hormone replacement therapy; collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
23. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
24. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
25. Inhibition of postmenopausal atherosclerosis progression: A comparison of the effects of conjugated equine estrogens and soy phytoestrogens
26. What role can diet play in the increased risk of cardiovascular disease in women aged 40 years and over?
27. Soy proteins and cardiovascular disease
28. A review of the evidence for the use of phytoetrogens as a replacement for traditional estrogen replacement therapy
29. Soy isoflavone improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women
30. Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein improves plasma lipids in ovariectomized cynomolgus monkeys
31. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women
32. Reducing bioavaible sex hormones through a comprehensive change in diet: The diet and androgens (DIANA) randomised trial
33. Postmenopausal hormone therapy: Less favourable risk-benefit ratios in healthy Dutch women
34. Postmenopausal hormone therapy and risk of stroke: The heart and Estrogen-progestin Replacement Study (HERS)
35. Meta-analysis of the effects of soy protein intake on serum lipids
36. The role of Isoflavones in menopausal health: Consensus opinion of the North American Menopause Society
37. Association of soy and fiber consumption with the risk of endometrial cancer